Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3912]
News [11314]
Articles [47]
Editorials [10]
Conferences [196]
elearning [4]
Genetically modified T cells fight haematological cancer
Dr Roman Galetto - Cellectis Therapeutics, Paris, France
Genetically modified T cells fight haematological cancer ( Dr Roman Galetto - Cellectis Therapeutics, Paris, France )
19 Jun 2014
Pivotal ruxolitinib data shows promise for patients with PV
Prof Alessandro Vannucchi - University of Florence, Florence, Italy
Pivotal ruxolitinib data shows promise for patients with PV ( Prof Alessandro Vannucchi - University of Florence, Florence, Italy )
19 Jun 2014
Novel Bcl-2 specific inhibitor updated results confirm substantial activity and...
Dr John Seymour - Peter MacCallum Cancer Centre, Melbourne, Australia
Novel Bcl-2 specific inhibitor updated results confirm substantial activity and durable responses in high-risk CLL ( Dr John Seymour - Peter MacCallum Cancer Centre, Melbourne, Australia )
19 Jun 2014
Does the use of generics of imatinib for chronic myeloid leukaemia jeopardise...
Dr Zafer Başlar - Istanbul University, Istanbul, Turkey
Does the use of generics of imatinib for chronic myeloid leukaemia jeopardise patient safety? ( Dr Zafer Başlar - Istanbul University, Istanbul, Turkey )
19 Jun 2014
Ibrutinib improves survival in CLL and SLL patients, RESONATE study shows
Prof Peter Hillmen - St James’ University Hospital, Leeds, UK
Ibrutinib improves survival in CLL and SLL patients, RESONATE study shows ( Prof Peter Hillmen - St James’ University Hospital, Leeds, UK )
19 Jun 2014
LHRH analogue goserelin helps preserve fertility among women undergoing chemo...
Dr Halle Moore - Taussig Cancer Institute, Cleveland, USA
LHRH analogue goserelin helps preserve fertility among women undergoing chemo for hormone receptor-negative breast cancer ( Dr Halle Moore - Taussig Cancer Institute, Cleveland, USA )
12 Jun 2014
Investigating anticarcinogenic compounds as an alternative to chemo
Dr Bernardo Bonnani - European Institute of Oncology, Milan, Italy
Investigating anticarcinogenic compounds as an alternative to chemo ( Dr Bernardo Bonnani - European Institute of Oncology, Milan, Italy )
6 Jun 2014
Importance of oncology nurses' work and research to cancer care
Sarah Liptrott - Eurpean Institute of Oncology, Milan, Italy
Importance of oncology nurses' work and research to cancer care ( Sarah Liptrott - Eurpean Institute of Oncology, Milan, Italy )
6 Jun 2014
Advances in diagnostic devices in melanoma screening
Dr Alessandro Testori - European Institute of Oncology, Milan, Italy
Advances in diagnostic devices in melanoma screening ( Dr Alessandro Testori - European Institute of Oncology, Milan, Italy )
6 Jun 2014
KRAS/NRAS and BRAF mutations in study of panitumumab plus FOLFIRI for second...
Prof Marc Peeters - University of Antwerp, Antwerp, Belgium
KRAS/NRAS and BRAF mutations in study of panitumumab plus FOLFIRI for second-line treatment of mCC ( Prof Marc Peeters - University of Antwerp, Antwerp, Belgium )
2 Jun 2014
Summary of breaking prostate news from ASCO 2014
Prof Eleni Efstathiou and Prof Gordon McVie
Summary of breaking prostate news from ASCO 2014 ( Prof Eleni Efstathiou and Prof Gordon McVie )
2 Jun 2014
PD-1 targeting immunotherapy MK-3475 has high, long-lasting activity against...
Dr Antoni Ribas – UCLA Jonsson Comprehensive Cancer Center, Los Angeles, US
PD-1 targeting immunotherapy MK-3475 has high, long-lasting activity against metastatic melanoma ( Dr Antoni Ribas – UCLA Jonsson Comprehensive Cancer Center, Los Angeles, US )
2 Jun 2014

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation